Literature DB >> 9739158

MPP+ toxicity and plasma membrane dopamine transporter: study using cell lines expressing the wild-type and mutant rat dopamine transporters.

S Kitayama1, C Mitsuhata, S Davis, J B Wang, T Sato, K Morita, G R Uhl, T Dohi.   

Abstract

The Parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium (MPP+) causes specific cell death in dopaminergic neurons after accumulation by the dopamine transporter (DAT). COS cells, a non-neuronal cell line insensitive to high doses of MPP+, becomes sensitive to MPP+ when transfected with the rat DAT cDNA. We analyzed the bi-directional transport of MPP+ and its toxicity in several cell lines expressing wild or mutant DATs. Cell death in COS cells expressing wild DAT by exposure to MPP+ was concentration-dependent and cocaine-reversible. Increased wild DAT expression caused higher sensitivities to the toxin in HeLa cells. Although several mutant DATs demonstrated greater transport activity than the wild-type, they displayed similar or lower sensitivity to MPP+ toxicity. Reverse transport of preloaded [3H]MPP+ through DAT was facilitated in COS cells expressing certain mutant DATs, which consistently displayed less sensitivity to MPP+ toxicity. These results suggest that re-distribution of MPP+ due to influx/efflux turnover through the transporter is a key factor in MPP+ toxicity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9739158     DOI: 10.1016/s0167-4889(98)00071-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding.

Authors:  Sathya Challasivakanaka; Juan Zhen; Margaret E Smith; Maarten E A Reith; James D Foster; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2017-09-22       Impact factor: 5.157

2.  1-Methyl-4-Phenylpyridinium-Induced Death of Differentiated SH-SY5Y Neurons Is Potentiated by Cholesterol.

Authors:  Anu Raju; Parasuram Jaisankar; Anupom Borah; Kochupurackal Parameswarannayar Mohanakumar
Journal:  Ann Neurosci       Date:  2017-10-30

3.  Distinct effects of rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on cellular bioenergetics and cell death.

Authors:  Samantha Giordano; Jisun Lee; Victor M Darley-Usmar; Jianhua Zhang
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

4.  Dopamine D2 agonists, bromocriptine and quinpirole, increase MPP+ -induced toxicity in PC12 cells.

Authors:  Keith Chiasson; Benoît Daoust; Daniel Levesque; Maria-Grazia Martinoli
Journal:  Neurotox Res       Date:  2006-08       Impact factor: 3.978

5.  Methylone and monoamine transporters: correlation with toxicity.

Authors:  Chiharu Sogawa; Norio Sogawa; Kazumi Ohyama; Ruri Kikura-Hanajiri; Yukihiro Goda; Ichiro Sora; Shigeo Kitayama
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

6.  In Vitro and in Vivo Neuroprotective Effects of Walnut (Juglandis Semen) in Models of Parkinson's Disease.

Authors:  Jin Gyu Choi; Gunhyuk Park; Hyo Geun Kim; Dal-Seok Oh; Hocheol Kim; Myung Sook Oh
Journal:  Int J Mol Sci       Date:  2016-01-15       Impact factor: 5.923

7.  The Short Isoform of DNAJB6 Protects against 1-Methyl-4-phenylpridinium Ion-Induced Apoptosis in LN18 Cells via Inhibiting Both ROS Formation and Mitochondrial Membrane Potential Loss.

Authors:  Yeon-Mi Hong; Yohan Hong; Yeong-Gon Choi; Sujung Yeo; Soo Hee Jin; Sae-Won Lee; Backil Sung; Sook-Hyun Lee; Hyejin Jung; Sabina Lim
Journal:  Oxid Med Cell Longev       Date:  2017-02-09       Impact factor: 6.543

8.  Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson's disease.

Authors:  Katja Stahl; Soulmaz Rahmani; Agnete Prydz; Nadia Skauli; Nanna MacAulay; Maria N Mylonakou; Reidun Torp; Øivind Skare; Torill Berg; Trygve B Leergaard; Ragnhild E Paulsen; Ole P Ottersen; Mahmood Amiry-Moghaddam
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

9.  The neurotoxin 1-methyl-4-phenylpyridinium (MPP(+)) alters hippocampal excitatory synaptic transmission by modulation of the GABAergic system.

Authors:  YuYing Huang; JunFang Chen; Ying Chen; YingHan Zhuang; Mu Sun; Thomas Behnisch
Journal:  Front Cell Neurosci       Date:  2015-08-04       Impact factor: 5.505

10.  Physiological characterisation of human iPS-derived dopaminergic neurons.

Authors:  Elizabeth M Hartfield; Michiko Yamasaki-Mann; Hugo J Ribeiro Fernandes; Jane Vowles; William S James; Sally A Cowley; Richard Wade-Martins
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.